No Standing Any Time

Published: April 3, 2024, 4:04 a.m.

b'The Supreme Court heard the case on the legality of FDA regulation of Mifepristone.\\xa0Issues of standing seemed to dominate, so Professor Amar treats us to a master class on standing - in this case, and its recent evolution.\\xa0He also suggests that at least one Justice might benefit by attending.\\xa0In a wide-ranging episode, we also share excitement and some new scholarly insights that emerged from the recent EverScholar program led by Akhil and others; and the Trump gag order gives rise to some musings as well.\\xa0There\\u2019s a lot for everyone in this episode, including CLE available from podcast.njsba.com.'